Forrest L. Baker

Exercise-mobilized donor lymphocytes enhance blinatumomab activity against B-ALL

Abstract Background Donor lymphocyte infusion (DLI) is used to prevent and treat leukemic relapse after allogeneic hematopoietic cell transplantation, although its efficacy against lymphoid malignancies remains limited. Blinatumomab (Blina), a CD3/CD19 bispecific T-cell engager,...